Segment-Wise Expectations for Novartis in Q2 2018
Analysts expect Novartis’s (NVS) second-quarter revenues to increase ~6.1% to ~$12.99 billion following growth in its operating revenues across all three segments. The chart below compares the company’s actual quarterly revenues since the first quarter of 2017 and analysts’ estimates for the second quarter.